Cargando…
DC-HIL-expressing Myelomonocytic Cells Are Critical Promoters of Melanoma Growth
A major barrier to successful cancer immunotherapy is the tumor’s ability to induce T-cell tolerance by exploiting host regulatory mechanisms. Having discovered the DC-HIL receptor, which inhibits T-cell responses by binding to syndecan-4 on effector T-cells, we posited the DC-HIL/syndecan-4 pathway...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199867/ https://www.ncbi.nlm.nih.gov/pubmed/24936834 http://dx.doi.org/10.1038/jid.2014.254 |